Josh Cohen
Founder bij AMYLYX PHARMACEUTICALS, INC.
Vermogen: 9 M $ op 31-03-2024
Profiel
Joshua B.
Cohen is the founder of Amylyx Pharmaceuticals, Inc., where he holds the title of Co-Chief Executive Officer & Executive Director since 2014.
He is also the founder of Brown Biotechnology Investment Group.
Mr. Cohen's current job is as a Director at Practice XYZ LLC.
Mr. Cohen's education includes an undergraduate degree from Brown University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-03-2024 | 3 023 002 ( 4.46% ) | 9 M $ | 31-03-2024 |
Actieve functies van Josh Cohen
| Bedrijven | Functie | Begin |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Founder | 01-01-2013 |
Practice XYZ LLC
 Practice XYZ LLC Internet Software/ServicesTechnology Services Practice XYZ, Inc. offers online platform which supports to share best practice videos. It offers corporate training, professional training, e-learning, online education, simulation training and video based training. The company was founded by Paul Tzen, Emily Foote and Karl S. Okamoto in 2011 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
Eerdere bekende functies van Josh Cohen
| Bedrijven | Functie | Einde |
|---|---|---|
| Brown Biotechnology Investment Group | Founder | - |
Opleiding van Josh Cohen
| Brown University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Practice XYZ, Inc. offers online platform which supports to share best practice videos. It offers corporate training, professional training, e-learning, online education, simulation training and video based training. The company was founded by Paul Tzen, Emily Foote and Karl S. Okamoto in 2011 and is headquartered in Philadelphia, PA. | Technology Services |
| Amylyx Pharmaceuticals, Inc. | |
| Brown Biotechnology Investment Group |
